• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Salvage hematopoietic cell transplantation for children with acute myeloid leukemia relapsed after first transplantation: a Japanese national registry study.

作者信息

Sakaguchi Hirotoshi, Taga Takashi, Ishida Hisashi, Hama Asahito, Okamoto Yasuhiro, Sano Hideki, Sato Maho, Koga Yuhki, Koh Katsuyoshi, Iwasaki Fuminori, Yoshida Nao, Cho Yuko, Okada Keiko, Watanabe Kentaro, Watanabe Akihiro, Hasegawa Daiichiro, Noguchi Maiko, Hashii Yoshiko, Matsumoto Kimikazu, Tabuchi Ken

机构信息

Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.

Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan.

出版信息

Bone Marrow Transplant. 2024 Nov;59(11):1621-1624. doi: 10.1038/s41409-024-02396-y. Epub 2024 Aug 22.

DOI:10.1038/s41409-024-02396-y
PMID:
39174743
Abstract
摘要

相似文献

1
Salvage hematopoietic cell transplantation for children with acute myeloid leukemia relapsed after first transplantation: a Japanese national registry study.首次移植后复发的儿童急性髓系白血病的挽救性造血细胞移植：一项日本全国性登记研究
Bone Marrow Transplant. 2024 Nov;59(11):1621-1624. doi: 10.1038/s41409-024-02396-y. Epub 2024 Aug 22.
2
[Sorafenib as salvage therapy in refractory relapsed acute myeloid leukemia with positive FLT3 mutation].[索拉非尼作为伴有FLT3基因突变阳性的难治性复发性急性髓系白血病的挽救治疗]
Zhonghua Xue Ye Xue Za Zhi. 2016 Apr;37(4):292-6. doi: 10.3760/cma.j.issn.0253-2727.2016.04.009.
3
The outcome of relapsed childhood acute lymphoblastic leukemia after allogeneic hematopoietic stem-cell transplantations: A single-center experience.异基因造血干细胞移植后儿童复发性急性淋巴细胞白血病的结局：单中心经验
Clin Transplant. 2024 May;38(5):e15366. doi: 10.1111/ctr.15366.
4
[Efficacy of CLAE Chemotherapy Regimen Followed by Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Leukemia].[CLAE化疗方案序贯异基因造血干细胞移植治疗复发/难治性急性白血病的疗效]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Jun;31(3):677-684. doi: 10.19746/j.cnki.issn.1009-2137.2023.03.010.
5
Modified cladribine, cytarabine, and G-CSF as a salvage regimen in patients with relapsed/refractory acute myeloid leukemia: a bridge to myeloablative allogeneic hematopoietic stem cell transplantation.用克拉屈滨、阿糖胞苷和 G-CSF 改良方案作为复发/难治性急性髓系白血病患者的挽救方案：桥接异基因造血干细胞移植。
Ann Hematol. 2019 Sep;98(9):2073-2080. doi: 10.1007/s00277-019-03723-w. Epub 2019 Jun 14.
6
Clinical Outcomes in Patients with FLT3-ITD-Mutated Relapsed/Refractory Acute Myelogenous Leukemia Undergoing Hematopoietic Stem Cell Transplantation after Quizartinib or Salvage Chemotherapy in the QuANTUM-R Trial.在 QUANTUM-R 试验中，接受 Quizartinib 或挽救性化疗后行造血干细胞移植的伴有 FLT3-ITD 突变的复发/难治性急性髓系白血病患者的临床结局。
Transplant Cell Ther. 2021 Feb;27(2):153-162. doi: 10.1016/j.bbmt.2020.09.036. Epub 2020 Oct 2.
7
Long-Term Follow-Up and Impact of Comorbidity before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia-Lessons Learned from the Prospective BRIDGE Trial.复发或难治性急性髓系白血病患者异基因造血干细胞移植前合并症的长期随访及影响——来自前瞻性BRIDGE试验的经验教训
Biol Blood Marrow Transplant. 2017 Sep;23(9):1491-1497. doi: 10.1016/j.bbmt.2017.05.014. Epub 2017 May 17.
8
Donor lymphocyte infusion for the treatment of relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.供体淋巴细胞输注治疗异基因造血干细胞移植后复发的急性髓系白血病：日本造血细胞移植学会成人急性髓系白血病工作组的回顾性分析
Biol Blood Marrow Transplant. 2014 Nov;20(11):1785-90. doi: 10.1016/j.bbmt.2014.07.010. Epub 2014 Jul 14.
9
[Sorafenib combined with chemotherapy and donor lymphocyte infusion as salvage therapy in patients with FLT3-positive acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation].索拉非尼联合化疗及供者淋巴细胞输注作为异基因造血干细胞移植后FLT3阳性急性髓系白血病复发患者的挽救治疗
Zhonghua Nei Ke Za Zhi. 2018 May 1;57(5):351-354. doi: 10.3760/cma.j.issn.0578-1426.2018.05.009.
10
Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.异基因造血干细胞移植后巨细胞病毒再激活与移植后存活至第100天的急性髓系白血病患者复发风险降低相关：日本造血细胞移植学会移植相关并发症工作组
Biol Blood Marrow Transplant. 2015 Nov;21(11):2008-16. doi: 10.1016/j.bbmt.2015.07.019. Epub 2015 Jul 26.

本文引用的文献

1
Second hematopoietic stem cell transplantation as salvage therapy for relapsed acute myeloid leukemia/myelodysplastic syndromes after a first transplantation.第一次移植后复发的急性髓系白血病/骨髓增生异常综合征的挽救性治疗：第二次造血干细胞移植。
Haematologica. 2023 Jul 1;108(7):1782-1792. doi: 10.3324/haematol.2022.281877.
2
Role of Second Transplantation for Children With Acute Myeloid Leukemia Following Posttransplantation Relapse.二次移植对急性髓系白血病儿童移植后复发的作用。
Pediatr Blood Cancer. 2016 Apr;63(4):701-5. doi: 10.1002/pbc.25866. Epub 2015 Dec 16.
3
Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data).
移植登记统一管理程序2（TRUMP2）介绍：TRUMP数据分析脚本，第一部分（非HLA相关数据的变量）
Int J Hematol. 2016 Jan;103(1):3-10. doi: 10.1007/s12185-015-1894-x. Epub 2015 Nov 7.
4
Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change.亲缘和非亲缘供者异基因造血干细胞移植后急性白血病血液学复发的二次移植：供者改变的作用。
J Clin Oncol. 2013 Sep 10;31(26):3259-71. doi: 10.1200/JCO.2012.44.7961. Epub 2013 Aug 5.